| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/02/2012 | CN101628045B Medicine for treating hemorrhoids and preparation method thereof |
| 05/02/2012 | CN101574450B Drug for treating heart disease and preparation method thereof |
| 05/02/2012 | CN101502536B Cedar total flavone as well as preparation method and medical use |
| 05/02/2012 | CN101480415B Cordyceps sinensis sustained and controlled release capsule and preparation method thereof |
| 05/02/2012 | CN101375990B Composition for treating cardiovascular disease and preparation thereof |
| 05/02/2012 | CN101367795B Imidazole-5-carboxylic acid derivant and method of preparing the same |
| 05/02/2012 | CA2719855A1 Temperature sensitive hydrogel and block copolymers |
| 05/01/2012 | US8168803 Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 05/01/2012 | US8168641 Aspartyl protease inhibitors |
| 05/01/2012 | US8168637 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 05/01/2012 | US8168619 Hormonal composition based on a progestational agent and an oestrogen and use thereof |
| 05/01/2012 | US8168616 Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
| 05/01/2012 | US8168587 Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases |
| 05/01/2012 | US8168416 Modified lecithin-cholesterol acyltransferase enzymes |
| 05/01/2012 | US8168198 Therapeutic agent for polycystic ovary syndrome (PCOS) |
| 05/01/2012 | US8168189 Protein A compositions and methods of use |
| 05/01/2012 | US8168160 Anti-inflammatory fusion protein |
| 05/01/2012 | CA2583910C Angiopoietin-2 specific binding agents |
| 05/01/2012 | CA2490722C Novel benzimidazole derivatives |
| 05/01/2012 | CA2437579C Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 05/01/2012 | CA2429625C Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof |
| 05/01/2012 | CA2404212C A process for the preparation of epothilone analogs and intermediates |
| 05/01/2012 | CA2333466C Gbs toxin receptor |
| 04/26/2012 | WO2012054718A2 Treating long qt syndrome |
| 04/26/2012 | WO2012054367A1 Rho kinase inhibitors |
| 04/26/2012 | WO2012054315A1 Cathepsin s inhibitor compounds |
| 04/26/2012 | WO2012053622A1 Non-human animal, cell, method for evaluation of blood pressure regulator, method for evaluation of condition for regulation of blood pressure, and method for regulation of blood pressure |
| 04/26/2012 | WO2012052555A1 Formulation comprising arginine, use and preparation thereof |
| 04/26/2012 | WO2012052205A1 Selective targeting of the cd40l/mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis |
| 04/26/2012 | WO2012027794A3 Method of treatment and agents useful for same |
| 04/26/2012 | WO2012014078A3 Method of treatment of organic diseases of nervous system, psychoorganic syndrome and encephalopathy |
| 04/26/2012 | WO2011156242A3 Improved anti-lysophospholipid antibody design using antibody structures |
| 04/26/2012 | WO2011135582A3 Pharmaceutical compositions of dronedarone |
| 04/26/2012 | WO2011103552A9 Amp derivatives for treating cardiac diseases |
| 04/26/2012 | US20120101427 Novel photosensitizer formulations for oral administration |
| 04/26/2012 | US20120101169 Methods of providing anticoagulation effects in subjects |
| 04/26/2012 | US20120101162 Methods and compositions for inducing physiological hypertrophy |
| 04/26/2012 | US20120101161 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 04/26/2012 | US20120101153 Rocaglaol derivatives as cardioprotectant agents and as antineoplastic agents |
| 04/26/2012 | US20120101149 Betulinic Acid Derivatives and Methods of Use Thereof |
| 04/26/2012 | US20120101138 Fluorinated aminotriazole derivatives |
| 04/26/2012 | US20120101136 5-membered heteroaryl derivatives used as sphingosine 1- phosphate receptor agonists |
| 04/26/2012 | US20120101134 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists |
| 04/26/2012 | US20120101128 Perhexiline for treating chronic heart failure |
| 04/26/2012 | US20120101126 Crystalline forms of pitavastatin calcium |
| 04/26/2012 | US20120101124 1,2,4-oxadiazol derivatives, their pharmaceutical compositions and their use as sphingosine 1-phosphate 1 receptor agonists |
| 04/26/2012 | US20120101112 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS |
| 04/26/2012 | US20120101105 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers |
| 04/26/2012 | US20120101095 Alkoxy-thienopyrimidines as tgf-beta receptor kinase modulators |
| 04/26/2012 | US20120101085 Compounds And Methods For Modulating Activity Of Calcium Release Channels |
| 04/26/2012 | US20120101083 S1p1 agonists comprising a bicyclic n-containing ring |
| 04/26/2012 | US20120101082 Vasopressin v1a antagonists |
| 04/26/2012 | US20120101075 Derivatives of 4-(2-Amino-1-Hydroxyethyl) Phenol as Agonists of the Beta2 Adrenergic Receptor |
| 04/26/2012 | US20120101068 Diphenyl sulfide derivatives and medicines containing same as active ingredient |
| 04/26/2012 | US20120101062 Lipase Inhibitors |
| 04/26/2012 | US20120101059 Sulphated hyaluronic acids as regulator agents of the cytokine activity |
| 04/26/2012 | US20120101058 Pharmaceutical Composition For Prevention Or Treatment Of Lifestyle-Related Disease, And Food Useful For Prevention Or Treatment Of Lifestyle-Related Disease |
| 04/26/2012 | US20120101052 15-thia steroid compounds and compositions |
| 04/26/2012 | US20120101046 Prophylactic or therapeutic agent for retinal disease and method for prophylaxis or therapy of retinal disease using jnk (c-jun amino-terminal kinase) - inhibitory peptide, and use of the peptide |
| 04/26/2012 | US20120101042 Agents and Methods for Tissue Repair and Regeneration |
| 04/26/2012 | US20120101040 angiogenesis inducing agent comprising recombinant gelatin |
| 04/26/2012 | US20120101029 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof |
| 04/26/2012 | US20120101028 Anti-inflammatory compounds and uses thereof |
| 04/26/2012 | US20120101026 Compounds For Enzyme Inhibition |
| 04/26/2012 | US20120101025 Compounds For Enzyme Inhibition |
| 04/26/2012 | US20120101021 Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy |
| 04/26/2012 | US20120100209 Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride |
| 04/26/2012 | US20120100208 Stable pharmaceutical composition and methods of using same |
| 04/26/2012 | US20120100204 TGF-Beta Stimulating Agent Compositions and Combinations |
| 04/26/2012 | US20120100178 Compositions And Methods For Treatment Of Microbial Infections |
| 04/26/2012 | US20120100161 Amatoxin-Armed Therapeutic Cell Surface Binding Components Designed for Tumour Therapy |
| 04/26/2012 | US20120100123 Compositions and methods for the prevention of cardiovascular disease |
| 04/26/2012 | US20120100112 Materials and methods for using adipose stem cells to treat lung injury and disease |
| 04/26/2012 | US20120100110 Physiological methods for isolation of high purity cell populations |
| 04/26/2012 | US20120100103 In situ forming hydrogel and biomedical use thereof |
| 04/26/2012 | US20120100074 Humanized antibodies against light and uses thereof |
| 04/26/2012 | US20120100069 B-Lymphocyte Targeting Agents for Use in a Method for the Treatment of a Disease |
| 04/26/2012 | DE102010049595A1 Chinazolinderivate Quinazoline derivatives |
| 04/26/2012 | CA2816033A1 Cathepsin s inhibitor compounds |
| 04/26/2012 | CA2815030A1 Selective targeting of the cd40l/mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis |
| 04/25/2012 | EP2444492A1 Chicken-derived anti-lox-1 antibody |
| 04/25/2012 | EP2444402A1 Compound having spiro-bonded cyclic group and use thereof |
| 04/25/2012 | EP2444401A1 Novel imidazopyridine compound |
| 04/25/2012 | EP2444395A1 Substituted isoquinoline derivative |
| 04/25/2012 | EP2444101A1 Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis |
| 04/25/2012 | EP2444097A1 Nfat signal inhibitor and calcineurin inhibitor |
| 04/25/2012 | EP2444094A1 Mangiferin-berberine salt, manufacturing method and use thereof |
| 04/25/2012 | EP2444089A2 Anhydrous compositions useful for attaining enhanced sexual wellness |
| 04/25/2012 | EP2443103A1 Oxabicyclo [4.1.o]hept-b-en-s-ylcarbamoyl derivatives inhibiting the nuclear factor-kappa(b) - (nf-kb) |
| 04/25/2012 | EP2443094A2 Process for the preparation of telmisartan |
| 04/25/2012 | EP2442793A1 Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them |
| 04/25/2012 | EP2225210B1 Dual-acting benzoimidazole derivative and their use as antihypertensive agents |
| 04/25/2012 | EP2129375B1 Imidazo[1,2-a]pyridines and their use as pharmaceuticals |
| 04/25/2012 | EP2089356B1 Salt of aliskiren with orotic acid |
| 04/25/2012 | EP1719768B1 Novel benzothiazepine and benzothiepine compounds |
| 04/25/2012 | EP1381432B9 HSA-free formulations of interferon-beta |
| 04/25/2012 | CN202198868U 治疗心经组织疾病的中药浆及包装 Treatment of cardiovascular medicine through tissue disease pulp and packaging |
| 04/25/2012 | CN202198839U 一种中药治疗脾经组织疾病的装置 A traditional Chinese medicine treatment of spleen tissue disease means |
| 04/25/2012 | CN1537014B HMGB1 protein inhibitors and/or antagonisis for treatment vascular diseases |
| 04/25/2012 | CN102428080A 神经营养因子活性参与的疾病的治疗或预防剂 Neurotrophic agent for treating or preventing diseases associated with the activity of Factor |